NCT00463684 - Live Attenuated Japanese Encephalitis (JE) Vaccine Coadministered With Measles Vaccine in Infants 9 Months of Age | Biotech Hunter

Enrollment

278

Participants

Timeline

Start Date

July 7, 2007

Primary Completion Date

November 7, 2007

Study Completion Date

October 6, 2008

Conditions

Japanese Encephalitis

Interventions

BIOLOGICAL

Live, Attenuated Japanese Encephalitis SA 14-14-2 Vaccine

Manufactured by Chengdu Institute of Biological Products (CDIBP), Chengdu, China; batch 200611A078-1. Administered subcutaneously in the right brachium.

BIOLOGICAL

Live, attenuated measles vaccine

Manufactured by Serum Institute of India, Ltd, Pune, India; batch EU3244. Administered subcutaneously in the left brachium.

Trial Locations (3)

Unknown

Homagama MOH Division Medical Office, Homagama

Kolonnawa MOH Division Medical Office, Kolonnawa

Moratuwa MOH Division Medical Office, Moratuwa

All Listed Sponsors

collaborator

Ministry of Health of Sri Lanka

UNKNOWN

collaborator

Mahidol University

OTHER

collaborator

Quintiles Singapore

UNKNOWN

lead

PATH

OTHER